Neutralization of plasmodium falciparum merozoites by antibodies against PfRH5

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 245-258

  Douglas, Alexander D ^a   Williams, Andrew R ^a,e   Knuepfer, Ellen ^b   Illingworth, Joseph J ^a   Furze, Julie M ^a   Crosnier, Cécile ^c   Choudhary, Prateek ^a   Bustamante, Leyla Y ^c   Zakutansky, Sara E ^a   Awuah, Dennis K ^a   Alanine, Daniel G W ^a   Theron, Michel ^c   Worth, Andrew ^a   Shimkets, Richard ^d   Rayner, Julian C ^c   Holder, Anthony A ^b   Wright, Gavin J ^c   Draper, Simon J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d Abeome   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD147 ANTIGEN; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RETICULOCYTE BINDING PROTEIN HOMOLOG 5; RETICULOCYTE BINDING PROTEIN HOMOLOG 5 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; EPITOPE MAPPING; IN VITRO STUDY; MEROZOITE; MOUSE; NONHUMAN; PARASITE CONTROL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 84891084707     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302045     Document Type: Article

References (52)

1. Murray, C. J., L. C. Rosenfeld, S. S. Lim, K. G. Andrews, K. J. Foreman, D. Haring, N. Fullman, M. Naghavi, R. Lozano, and A. D. Lopez. 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
2. Birkett, A. J., V. S. Moorthy, C. Loucq, C. E. Chitnis, and D. C. Kaslow. 2013. Malaria vaccine R&D in the decade of vaccines: breakthroughs, challenges and opportunities. Vaccine 31(Suppl. 2): B233-B243.
3. Goodman, A. L., and S. J. Draper. 2010. Blood-stage malaria vaccines: recent progress and future challenges. Ann. Trop. Med. Parasitol. 104: 189-211.
4. Genton, B., I. Betuela, I. Felger, F. Al-Yaman, R. F. Anders, A. Saul, L. Rare, M. Baisor, K. Lorry, G. V. Brown, et al. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 185: 820-827.
5. Thera, M. A., O. K. Doumbo, D. Coulibaly, M. B. Laurens, A. Ouattara, A. K. Kone, A. B. Guindo, K. Traore, I. Traore, B. Kouriba, et al. 2011. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365: 1004-1013.
6. Dutta, S., J. S. Sullivan, K. K. Grady, J. D. Haynes, J. Komisar, A. H. Batchelor, L. Soisson, C. L. Diggs, D. G. Heppner, D. E. Lanar, et al. 2009. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model. PLoS One 4: e8138.
7. Lyon, J. A., E. Angov, M. P. Fay, J. S. Sullivan, A. S. Girourd, S. J. Robinson, E. S. Bergmann-Leitner, E. H. Duncan, C. A. Darko, W. E. Collins, et al. 2008. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses. PLoS One 3: e2830.
8. Douglas, A. D., A. R. Williams, J. J. Illingworth, G. Kamuyu, S. Biswas, A. L. Goodman, D. H. Wyllie, C. Crosnier, K. Miura, G. J. Wright, et al. 2011. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2: 601.
9. Williams, A. R., A. D. Douglas, K. Miura, J. J. Illingworth, P. Choudhary, L. M. Murungi, J. M. Furze, A. Diouf, O. Miotto, C. Crosnier, et al. 2012. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog. 8: e1002991.
10. Bustamante, L. Y., S. J. Bartholdson, C. Crosnier, M. G. Campos, M. Wanaguru, C. Nguon, D. P. Kwiatkowski, G. J. Wright, and J. C. Rayner. 2013. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine 31: 373-379.
11. Villasis, E., M. Lopez-Perez, K. Torres, D. Gamboa, V. Neyra, J. Bendezu, N. Tricoche, C. Lobo, J. M. Vinetz, and S. Lustigman. 2012. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malar. J. 11: 361.
12. Riglar, D. T., D. Richard, D. W. Wilson, M. J. Boyle, C. Dekiwadia, L. Turnbull, F. Angrisano, D. S. Marapana, K. L. Rogers, C. B. Whitchurch, et al. 2011. Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 9: 9-20.
13. Tham, W. H., J. Healer, and A. F. Cowman. 2012. Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum. Trends Parasitol. 28: 23-30.
14. Cowman, A. F., D. Berry, and J. Baum. 2012. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol. 198: 961-971.
15. Singh, S., M. M. Alam, I. Pal-Bhowmick, J. A. Brzostowski, and C. E. Chitnis. 2010. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog. 6: e1000746.
16. Crosnier, C., L. Y. Bustamante, S. J. Bartholdson, A. K. Bei, M. Theron, M. Uchikawa, S. Mboup, O. Ndir, D. P. Kwiatkowski, M. T. Duraisingh, et al. 2011. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480: 534-537.
17. Moss, D. K., E. J. Remarque, B. W. Faber, D. R. Cavanagh, D. E. Arnot, A. W. Thomas, and A. A. Holder. 2012. Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development. Infect. Immun. 80: 1280-1287.
18. Srinivasan, P., W. L. Beatty, A. Diouf, R. Herrera, X. Ambroggio, J. K. Moch, J. S. Tyler, D. L. Narum, S. K. Pierce, J. C. Boothroyd, et al. 2011. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl. Acad. Sci. USA 108: 13275-13280.
19. Dutta, S., J. D. Haynes, A. Barbosa, L. A. Ware, J. D. Snavely, J. K. Moch, A. W. Thomas, and D. E. Lanar. 2005. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Infect. Immun. 73: 2116-2122.
20. de Cassan, S. C., E. K. Forbes, A. D. Douglas, A. Milicic, B. Singh, P. Gupta, V. S. Chauhan, C. E. Chitnis, S. C. Gilbert, A. V. Hill, and S. J. Draper. 2011. The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus. J. Immunol. 187: 2602-2616.
21. Kaneko, O., J. Mu, T. Tsuboi, X. Su, and M. Torii. 2002. Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol. Biochem. Parasitol. 121: 275-278.
22. Goodman, A. L., A. M. Blagborough, S. Biswas, Y. Wu, A. V. Hill, R. E. Sinden, and S. J. Draper. 2011. A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. PLoS One 6: e29428.
23. Draper, S. J., A. C. Moore, A. L. Goodman, C. A. Long, A. A. Holder, S. C. Gilbert, F. Hill, and A. V. Hill. 2008. Effective induction of high-titer antibodies by viral vector vaccines. Nat. Med. 14: 819-821.
24. Goodman, A. L., C. Epp, D. Moss, A. A. Holder, J. M. Wilson, G. P. Gao, C. A. Long, E. J. Remarque, A. W. Thomas, V. Ammendola, et al. 2010. New candidate vaccines against blood-stage Plasmodium falciparum malaria: primeboost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1. Infect. Immun. 78: 4601-4612.
25. Boyle, M. J., D. W. Wilson, J. S. Richards, D. T. Riglar, K. K. Tetteh, D. J. Conway, S. A. Ralph, J. Baum, and J. G. Beeson. 2010. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Natl. Acad. Sci. USA 107: 14378-14383.
26. Schofield, L., G. R. Bushell, J. A. Cooper, A. J. Saul, J. A. Upcroft, and C. Kidson. 1986. A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies. Mol. Biochem. Parasitol. 18: 183-195.
27. Roger, N., J. F. Dubremetz, P. Delplace, B. Fortier, G. Tronchin, and A. Vernes. 1988. Characterization of a 225 kilodalton rhoptry protein of Plasmodium falciparum. Mol. Biochem. Parasitol. 27: 135-141.
28. Kusi, K. A., B. W. Faber, A. W. Thomas, and E. J. Remarque. 2009. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity. PLoS One 4: e8110.
29. Holder, A. A., R. R. Freeman, S. Uni, and M. Aikawa. 1985. Isolation of a Plasmodium falciparum rhoptry protein. Mol. Biochem. Parasitol. 14: 293-303.
30. Knuepfer, E., O. Suleyman, A. R. Dluzewski, U. Straschil, A. H. O'Keeffe, S. A. Ogun, J. L. Green, M. Grainger, R. Tewari, and A. A. Holder. 2013. RON12, a novel Plasmodium-specific rhoptry neck protein important for parasite proliferation. Cell. Microbiol. doi:10.1111/cmi.12181
31. Gerold, P., L. Schofield, M. J. Blackman, A. A. Holder, and R. T. Schwarz. 1996. Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol. Biochem. Parasitol. 75: 131-143.
32. Green, J. L., R. R. Rees-Channer, S. A. Howell, S. R. Martin, E. Knuepfer, H. M. Taylor, M. Grainger, and A. A. Holder. 2008. The motor complex of Plasmodium falciparum: phosphorylation by a calcium-dependent protein kinase. J. Biol. Chem. 283: 30980-30989.
33. Price, P. W., E. C. McKinney, Y. Wang, L. E. Sasser, M. K. Kandasamy, L. Matsuuchi, C. Milcarek, R. B. Deal, D. G. Culver, and R. B. Meagher. 2009. Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas. J. Immunol. Methods 343: 28-41.
34. Bartholdson, S. J., C. Crosnier, L. Y. Bustamante, J. C. Rayner, and G. J. Wright. 2013. Identifying novel Plasmodium falciparum erythrocyte invasion receptors using systematic extracellular protein interaction screens. Cell. Microbiol. 15: 1304-1312.
35. Rodriguez, M., S. Lustigman, E. Montero, Y. Oksov, and C. A. Lobo. 2008. PfRH5: a novel reticulocyte-binding family homolog of Plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor. PLoS One 3: e3300.
36. Baum, J., L. Chen, J. Healer, S. Lopaticki, M. Boyle, T. Triglia, F. Ehlgen, S. A. Ralph, J. G. Beeson, and A. F. Cowman. 2009. Reticulocyte-binding protein homologue 5: an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 39: 371-380.
37. Hayton, K., D. Gaur, A. Liu, J. Takahashi, B. Henschen, S. Singh, L. Lambert, T. Furuya, R. Bouttenot, M. Doll, et al. 2008. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4: 40-51.
38. Chen, L., S. Lopaticki, D. T. Riglar, C. Dekiwadia, A. D. Uboldi, W. H. Tham, M. T. O'Neill, D. Richard, J. Baum, S. A. Ralph, and A. F. Cowman. 2011. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 7: e1002199.
39. Zuccala, E. S., A. M. Gout, C. Dekiwadia, D. S. Marapana, F. Angrisano, L. Turnbull, D. T. Riglar, K. L. Rogers, C. B. Whitchurch, S. A. Ralph, et al. 2012. Subcompartmentalisation of proteins in the rhoptries correlates with ordered events of erythrocyte invasion by the blood stage malaria parasite. PLoS One 7: e46160.
40. Salmon, B. L., A. Oksman, and D. E. Goldberg. 2001. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc. Natl. Acad. Sci. USA 98: 271-276.
41. Delgado, M. F., S. Coviello, A. C. Monsalvo, G. A. Melendi, J. Z. Hernandez, J. P. Batalle, L. Diaz, A. Trento, H. Y. Chang, W. Mitzner, et al. 2009. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 15: 34-41.
42. Gilson, P. R., and B. S. Crabb. 2009. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int. J. Parasitol. 39: 91-96.
43. Saul, A. 1987. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 9: 1-9.
44. Collins, C. R., C. Withers-Martinez, G. A. Bentley, A. H. Batchelor, A. W. Thomas, and M. J. Blackman. 2007. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J. Biol. Chem. 282: 7431-7441.
45. Singh, S., M. Plassmeyer, D. Gaur, and L. H. Miller. 2007. Mononeme: a new secretory organelle in Plasmodium falciparum merozoites identified by localization of rhomboid-1 protease. Proc. Natl. Acad. Sci. USA 104: 20043-20048.
46. Yeoh, S., R. A. O'Donnell, K. Koussis, A. R. Dluzewski, K. H. Ansell, S. A. Osborne, F. Hackett, C. Withers-Martinez, G. H. Mitchell, L. H. Bannister, et al. 2007. Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell 131: 1072-1083.
47. Coley, A. M., K. Parisi, R. Masciantonio, J. Hoeck, J. L. Casey, V. J. Murphy, K. S. Harris, A. H. Batchelor, R. F. Anders, and M. Foley. 2006. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect. Immun. 74: 2628-2636.
48. Chitnis, C. E., and A. Sharma. 2008. Targeting the Plasmodium vivax Duffybinding protein. Trends Parasitol. 24: 29-34.
49. Poulsen, T. R., A. Jensen, J. S. Haurum, and P. S. Andersen. 2011. Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans. J. Immunol. 187: 4229-4235.
50. Spring, M. D., J. F. Cummings, C. F. Ockenhouse, S. Dutta, R. Reidler, E. Angov, E. Bergmann-Leitner, V. A. Stewart, S. Bittner, L. Juompan, et al. 2009. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One 4: e5254.
51. Sheehy, S. H., C. J. Duncan, S. C. Elias, K. A. Collins, K. J. Ewer, A. J. Spencer, A. R. Williams, F. D. Halstead, S. E. Moretz, K. Miura, et al. 2011. Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors. Mol. Ther. 19: 2269-2276.
52. Reddy, S. B., R. F. Anders, J. G. Beeson, A. Färnert, F. Kironde, S. K. Berenzon, M. Wahlgren, S. Linse, and K. E. Persson. 2012. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One 7: e32242.